Tsz Kit Chow, Rex Pui Kin Lam, Chi Keung Chan, Man Li Tse, Yibin Feng, Timothy Hudson Rainer
{"title":"香港发生急性苦参生物碱中毒。","authors":"Tsz Kit Chow, Rex Pui Kin Lam, Chi Keung Chan, Man Li Tse, Yibin Feng, Timothy Hudson Rainer","doi":"10.1016/j.toxicon.2025.108251","DOIUrl":null,"url":null,"abstract":"<p><p>Sophora alkaloids, including matrine, oxymatrine, and sophoridine, are quinolizidines found in plants used in traditional Chinese medicine such as Sophora flavescens and Sophora tonkinensis. Reports on acute Sophora alkaloid poisoning in humans outside of mainland China are lacking. This study aimed to characterize the clinical presentations, management, and outcomes of acute poisoning involving Sophora alkaloids in Hong Kong. We conducted a retrospective study of patients who were reported to the Hong Kong Poison Control Centre from all public emergency departments (EDs) in Hong Kong for acute poisoning involving Sophora alkaloids. Exposure was confirmed by laboratories, and data were collected between July 1, 2008 and June 30, 2021. We also analyzed patient demographics, clinical, management, and outcome characteristics. Among the 83 cases analyzed, S. flavescens was the major source (77.1%) of Sophora alkaloids and excessive dose was common (39.0%). Most patients (90.4%) had minor effects. Common clinical presentations were dizziness (83.1%), vomiting (72.3%), and palpitations (32.5%). No acute liver or kidney injuries or adverse skin reactions were observed. Treatment was primarily supportive and no patients underwent gastrointestinal decontamination, organ support treatment, or renal replacement therapy. Most patients (74.7%) were observed in the ED and only one required close monitoring in a cardiac care unit for prolonged QT interval after concurrent ciprofloxacin use. In contrast to the intravenous administration of S. flavescens, no adverse skin reactions were seen after oral consumption. Hepatoxicity, reported in in vitro and animal studies, and isolated human case reports, was not observed. In conclusion, excessive dose of S. flavescens is a common cause of acute Sophora alkaloid poisoning. Although most patients had mild symptoms, discrepancies in clinical presentations resulting from different formulations and varied experimental/clinical conditions call for further studies to evaluate the real-world risks of skin reactions and hepatoxicity of Sophora alkaloids.</p>","PeriodicalId":23289,"journal":{"name":"Toxicon","volume":" ","pages":"108251"},"PeriodicalIF":2.6000,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Acute Sophora alkaloid poisoning in Hong Kong.\",\"authors\":\"Tsz Kit Chow, Rex Pui Kin Lam, Chi Keung Chan, Man Li Tse, Yibin Feng, Timothy Hudson Rainer\",\"doi\":\"10.1016/j.toxicon.2025.108251\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Sophora alkaloids, including matrine, oxymatrine, and sophoridine, are quinolizidines found in plants used in traditional Chinese medicine such as Sophora flavescens and Sophora tonkinensis. Reports on acute Sophora alkaloid poisoning in humans outside of mainland China are lacking. This study aimed to characterize the clinical presentations, management, and outcomes of acute poisoning involving Sophora alkaloids in Hong Kong. We conducted a retrospective study of patients who were reported to the Hong Kong Poison Control Centre from all public emergency departments (EDs) in Hong Kong for acute poisoning involving Sophora alkaloids. Exposure was confirmed by laboratories, and data were collected between July 1, 2008 and June 30, 2021. We also analyzed patient demographics, clinical, management, and outcome characteristics. Among the 83 cases analyzed, S. flavescens was the major source (77.1%) of Sophora alkaloids and excessive dose was common (39.0%). Most patients (90.4%) had minor effects. Common clinical presentations were dizziness (83.1%), vomiting (72.3%), and palpitations (32.5%). No acute liver or kidney injuries or adverse skin reactions were observed. Treatment was primarily supportive and no patients underwent gastrointestinal decontamination, organ support treatment, or renal replacement therapy. Most patients (74.7%) were observed in the ED and only one required close monitoring in a cardiac care unit for prolonged QT interval after concurrent ciprofloxacin use. In contrast to the intravenous administration of S. flavescens, no adverse skin reactions were seen after oral consumption. Hepatoxicity, reported in in vitro and animal studies, and isolated human case reports, was not observed. In conclusion, excessive dose of S. flavescens is a common cause of acute Sophora alkaloid poisoning. Although most patients had mild symptoms, discrepancies in clinical presentations resulting from different formulations and varied experimental/clinical conditions call for further studies to evaluate the real-world risks of skin reactions and hepatoxicity of Sophora alkaloids.</p>\",\"PeriodicalId\":23289,\"journal\":{\"name\":\"Toxicon\",\"volume\":\" \",\"pages\":\"108251\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-01-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Toxicon\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.toxicon.2025.108251\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Toxicon","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.toxicon.2025.108251","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Sophora alkaloids, including matrine, oxymatrine, and sophoridine, are quinolizidines found in plants used in traditional Chinese medicine such as Sophora flavescens and Sophora tonkinensis. Reports on acute Sophora alkaloid poisoning in humans outside of mainland China are lacking. This study aimed to characterize the clinical presentations, management, and outcomes of acute poisoning involving Sophora alkaloids in Hong Kong. We conducted a retrospective study of patients who were reported to the Hong Kong Poison Control Centre from all public emergency departments (EDs) in Hong Kong for acute poisoning involving Sophora alkaloids. Exposure was confirmed by laboratories, and data were collected between July 1, 2008 and June 30, 2021. We also analyzed patient demographics, clinical, management, and outcome characteristics. Among the 83 cases analyzed, S. flavescens was the major source (77.1%) of Sophora alkaloids and excessive dose was common (39.0%). Most patients (90.4%) had minor effects. Common clinical presentations were dizziness (83.1%), vomiting (72.3%), and palpitations (32.5%). No acute liver or kidney injuries or adverse skin reactions were observed. Treatment was primarily supportive and no patients underwent gastrointestinal decontamination, organ support treatment, or renal replacement therapy. Most patients (74.7%) were observed in the ED and only one required close monitoring in a cardiac care unit for prolonged QT interval after concurrent ciprofloxacin use. In contrast to the intravenous administration of S. flavescens, no adverse skin reactions were seen after oral consumption. Hepatoxicity, reported in in vitro and animal studies, and isolated human case reports, was not observed. In conclusion, excessive dose of S. flavescens is a common cause of acute Sophora alkaloid poisoning. Although most patients had mild symptoms, discrepancies in clinical presentations resulting from different formulations and varied experimental/clinical conditions call for further studies to evaluate the real-world risks of skin reactions and hepatoxicity of Sophora alkaloids.
期刊介绍:
Toxicon has an open access mirror Toxicon: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review. An introductory offer Toxicon: X - full waiver of the Open Access fee.
Toxicon''s "aims and scope" are to publish:
-articles containing the results of original research on problems related to toxins derived from animals, plants and microorganisms
-papers on novel findings related to the chemical, pharmacological, toxicological, and immunological properties of natural toxins
-molecular biological studies of toxins and other genes from poisonous and venomous organisms that advance understanding of the role or function of toxins
-clinical observations on poisoning and envenoming where a new therapeutic principle has been proposed or a decidedly superior clinical result has been obtained.
-material on the use of toxins as tools in studying biological processes and material on subjects related to venom and antivenom problems.
-articles on the translational application of toxins, for example as drugs and insecticides
-epidemiological studies on envenoming or poisoning, so long as they highlight a previously unrecognised medical problem or provide insight into the prevention or medical treatment of envenoming or poisoning. Retrospective surveys of hospital records, especially those lacking species identification, will not be considered for publication. Properly designed prospective community-based surveys are strongly encouraged.
-articles describing well-known activities of venoms, such as antibacterial, anticancer, and analgesic activities of arachnid venoms, without any attempt to define the mechanism of action or purify the active component, will not be considered for publication in Toxicon.
-review articles on problems related to toxinology.
To encourage the exchange of ideas, sections of the journal may be devoted to Short Communications, Letters to the Editor and activities of the affiliated societies.